金河生物：10月13日召开董事会会议

Group 1 - The core point of the article is that Jinhe Biology announced the convening of its 32nd meeting of the sixth board of directors, which reviewed the proposal to amend the internal reporting system for significant matters [1] - For the first half of 2025, Jinhe Biology's revenue composition is as follows: veterinary chemical drugs accounted for 61.83%, agricultural product processing accounted for 19.76%, veterinary biological products accounted for 11.12%, environmental protection business accounted for 4.97%, and others accounted for 2.15% [1] - As of the report date, Jinhe Biology has a market capitalization of 5.4 billion yuan [1]